BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 21538846)

  • 41. Green tea polyphenols in the prevention of colon cancer.
    Kumar N; Shibata D; Helm J; Coppola D; Malafa M
    Front Biosci; 2007 Jan; 12():2309-15. PubMed ID: 17127241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma.
    Huang W; Ding L; Huang Q; Hu H; Liu S; Yang X; Hu X; Dang Y; Shen S; Li J; Ji X; Jiang S; Liu JO; Yu L
    Hepatology; 2010 Aug; 52(2):703-14. PubMed ID: 20683966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance.
    Yang CS; Wang X; Lu G; Picinich SC
    Nat Rev Cancer; 2009 Jun; 9(6):429-39. PubMed ID: 19472429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Green tea regulates cell cycle progression in oral leukoplakia.
    Khafif A; Schantz SP; al-Rawi M; Edelstein D; Sacks PG
    Head Neck; 1998 Sep; 20(6):528-34. PubMed ID: 9702540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Green tea: prevention and treatment of cancer by nutraceuticals.
    Béliveau R; Gingras D
    Lancet; 2004 Sep 18-24; 364(9439):1021-2. PubMed ID: 15380952
    [No Abstract]   [Full Text] [Related]  

  • 46. Molecular targets for green tea in prostate cancer prevention.
    Adhami VM; Ahmad N; Mukhtar H
    J Nutr; 2003 Jul; 133(7 Suppl):2417S-2424S. PubMed ID: 12840218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail.
    Bode AM; Dong Z
    Cancer Prev Res (Phila); 2009 Jun; 2(6):514-7. PubMed ID: 19470792
    [No Abstract]   [Full Text] [Related]  

  • 48. Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts.
    Patra SK; Rizzi F; Silva A; Rugina DO; Bettuzzi S
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():217-35. PubMed ID: 19261982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Catechin-vanilloid synergies with potential clinical applications in cancer.
    Morré DM; Morré DJ
    Rejuvenation Res; 2006; 9(1):45-55. PubMed ID: 16608395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tea and cancer prevention: molecular mechanisms and human relevance.
    Yang CS; Lambert JD; Ju J; Lu G; Sang S
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):265-73. PubMed ID: 17234229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways.
    Lin JK
    Arch Pharm Res; 2002 Oct; 25(5):561-71. PubMed ID: 12433185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A potential proliferative gene, NUDT6, is down-regulated by green tea catechins at the posttranscriptional level.
    Sukhthankar M; Choi CK; English A; Kim JS; Baek SJ
    J Nutr Biochem; 2010 Feb; 21(2):98-106. PubMed ID: 19157820
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer Preventive Activities of Tea Catechins.
    Yang CS; Wang H
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27941682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation.
    Lamy S; Gingras D; Béliveau R
    Cancer Res; 2002 Jan; 62(2):381-5. PubMed ID: 11809684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg.
    Annabi B; Currie JC; Moghrabi A; Béliveau R
    Leuk Res; 2007 Sep; 31(9):1277-84. PubMed ID: 17081606
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of tea constituents on cell cycle progression of human leukemia U937 cells.
    Ohata M; Koyama Y; Suzuki T; Hayakawa S; Saeki K; Nakamura Y; Isemura M
    Biomed Res; 2005 Feb; 26(1):1-7. PubMed ID: 15806977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies.
    Shanafelt TD; Lee YK; Call TG; Nowakowski GS; Dingli D; Zent CS; Kay NE
    Leuk Res; 2006 Jun; 30(6):707-12. PubMed ID: 16325256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemoprevention of dibenzo[a,l]pyrene transplacental carcinogenesis in mice born to mothers administered green tea: primary role of caffeine.
    Castro DJ; Yu Z; Löhr CV; Pereira CB; Giovanini JN; Fischer KA; Orner GA; Dashwood RH; Williams DE
    Carcinogenesis; 2008 Aug; 29(8):1581-6. PubMed ID: 18635525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antioxidants regulate normal human keratinocyte differentiation.
    Eckert RL; Crish JF; Efimova T; Balasubramanian S
    Biochem Pharmacol; 2004 Sep; 68(6):1125-31. PubMed ID: 15313409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture.
    Conney AH
    Cancer Res; 2003 Nov; 63(21):7005-31. PubMed ID: 14612489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.